Acasă › Glioblastom › Texas › Houston
Studii clinice pentru Glioblastom în Houston, TX
25 studii pentru Glioblastom caută participanți în și în jurul orașului Houston (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
În curs de recrutareFaza 2/3
- University of Texas - MD Anderson Cancer Center, Houston
GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
În curs de recrutareFaza 1
- Baylor St. Luke's Medical Center, Houston
A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
În curs de recrutareFaza 1
- MD Anderson Cancer Center, Houston
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
În curs de recrutareFaza 1/2
- Baylor College of Medicine, Houston
MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
În curs de recrutareFaza 1
- M D Anderson Cancer Center, Houston
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
În curs de recrutareFaza 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Anti-GD2 ADC M3554 in Advanced Solid Tumors
În curs de recrutareFaza 1
- The University of Texas MD Anderson Cancer Center, Houston
Targeted Pediatric High-Grade Glioma Therapy
În curs de recrutareStudiu observațional
- Texas Children's Hospital, Houston
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
În curs de recrutareFaza 1
- MD Anderson Cancer Center, Houston
Study of Olutasidenib and Temozolomide in HGG
În curs de recrutareFaza 2
- Texas Children's Hospital, Houston
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
În curs de recrutareFaza 3
- MD Anderson Cancer Center, Houston
A Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent Glioblastoma
În curs de recrutareFaza 1
- MD Anderson Cancer Center, Houston
Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)
În curs de recrutareFaza 1
- Excel Diagnostics & Nuclear Oncology Center, Houston
A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma
În curs de recrutareFaza 1/2
- The University of Texas M. D. Anderson Cancer Center, Houston
- The University of Texas MD Anderson Cancer Center, Houston
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
În curs de recrutareVoluntari sănătoși bineveniți
- M D Anderson Cancer Center, Houston
Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas
În curs de recrutareFaza 2
- M D Anderson Cancer Center, Houston
DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
În curs de recrutareFaza 2
- UTHealth Houston, Houston
- Baylor College of Medicine, Houston
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
În curs de recrutareFaza 1 timpurieVoluntari sănătoși bineveniți
- Texas Children's Hospital, Houston
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
În curs de recrutareFaza 2
- Texas Children's Hospital, Houston
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
În curs de recrutareFaza 1/2
- MD Anderson Cancer Center, Houston
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
În curs de recrutareFaza 1/2
- Houston Methodist Neurological Institute, Houston
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
În curs de recrutareFaza 1/2
- Houston Methodist Neurological Institute, Houston
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
În curs de recrutareStudiu observațional
- Massive Bio SYNERGY-AI site, Houston
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
În curs de recrutareFaza 1/2
- MD Anderson Cancer Center, Houston
Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
În curs de recrutareFaza 1
- UT MD Anderson Cancer Center, Houston
Studii pentru Glioblastom în alte orașe
- New York City, NY30 studii
- Boston, MA28 studii
- Los Angeles, CA23 studii
- Durham, NC20 studii
- San Francisco, CA17 studii
- Washington, DC15 studii
- Chicago, IL15 studii
- Rochester, MN15 studii
- Columbus, OH14 studii
- Miami, FL14 studii
- Jacksonville, FL13 studii
- Aurora, CO12 studii
Alte studii în Houston
- Cancer pulmonar cu celule non-pătrate145 studii
- Cancer de sân126 studii
- Cancer (toate tipurile)121 studii
- Cancer metastatic104 studii
- Cancer colorectal102 studii
- Cancer ovarian89 studii
- Leucemie mieloasă acută85 studii
- Cancer pulmonar78 studii
- Cancer de prostată76 studii
- Cancer endometrial68 studii
- Cancer pancreatic61 studii
- Melanom59 studii
Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.